LY3023414 has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, BREAST CANCER, and Advanced Cancer, among others.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.